A further objective of this study was to assess potential improvements of the PC-3 tumor targeting and overall pharmacokinetics of [99mTc]Tc-DB7, [99mTc]Tc-DB13, and [99mTc]Tc-DB14 during transient inhibition of neprilysin (NEP) [25,26]. The gene discussed is MME; the disease is neoplasm.